Rechercher | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Affichage: 1 result.

- Article de périodique
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
Spicer, James Marabelle, Aurélien Baurain, Jean-François[UCL] Jebsen, Nina Louise Jøssang, Dag Erik Awada, Ahmad Kristeleit, Rebecca Loirat, Delphine Lazaridis, George Jungels, Christiane Brunsvig, Paal Nicolaisen, Berit Saunders, Andrew Patel, Hamina Galon, Jérôme Hermitte, Fabienne Camilio, Ketil André Mauseth, Brynjar Sundvold, Vibeke Sveinbjørnsson, Baldur Rekdal, Øystein (2021) Clinical cancer research — Vol. 27, no. 10, p. 2755-2763 (2021)